Viewing Study NCT03816332


Ignite Creation Date: 2025-12-24 @ 9:48 PM
Ignite Modification Date: 2026-03-29 @ 5:45 PM
Study NCT ID: NCT03816332
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-09
First Post: 2019-01-24
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Tacrolimus, Nivolumab, and Ipilimumab in Treating Kidney Transplant Recipients With Selected Unresectable or Metastatic Cancers
Sponsor: National Cancer Institute (NCI)
Organization: